Nvidia's China Lifeline
This carefully selected group of stocks represents companies set to benefit from Nvidia resuming AI chip sales to China. Handpicked by professional analysts, these investments span the entire supply chain from chip designers to the Chinese tech giants who will use this technology to power their AI ambitions.
Your Basket's Financial Footprint
Interpretation of the basket market capitalisation data for investor guidance.
- Large-cap dominance generally means lower volatility and performance that more closely tracks broader markets, likely providing stability.
- Use this basket as a core holding for diversification rather than a speculative, high-risk trade.
- Expect steady, long-term value gains rather than explosive short-term growth; returns will likely be gradual.
NVDA: $4.40T
BIDU: $40.96B
TSM: $1.23T
- Other
About This Group of Stocks
Our Expert Thinking
Nvidia's strategic move to resume H20 AI chip sales to China represents a major market reopening that benefits the entire tech ecosystem. These stocks capture the ripple effect across the value chain, from chip manufacturing and server assembly to memory production and AI application development in China.
What You Need to Know
This investment opportunity focuses on companies directly benefiting from Nvidia's pivot to navigate trade restrictions. The renewed access to high-performance chips could signal improving US-China tech relations and unlock substantial revenue streams for companies throughout the semiconductor supply chain.
Why These Stocks
We've assembled companies spanning the complete ecosystem that will benefit from this policy change. This includes Nvidia itself, Chinese tech giants regaining access to critical hardware, and the global suppliers essential for chip production, server assembly, and memory components.
Why You'll Want to Watch These Stocks
Market Access Unlocked
Nvidia's strategic pivot reopens a massive, previously restricted market. These companies are first in line to benefit from China's renewed access to cutting-edge AI hardware.
Global Supply Chain Winners
From chip designers to memory makers, each company in this group represents a critical link in the newly revitalized AI supply chain spanning the US and China.
AI Acceleration Potential
Chinese tech giants have been waiting for these chips to power their AI ambitions. With restrictions easing, expect accelerated development and potential market gains.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Drug Pricing Power | Major Pharma Stocks 2025
Following plans by major drugmakers to raise prices on hundreds of medications, the pharmaceutical industry is showcasing its significant pricing power. This development highlights an investment opportunity centered on established pharmaceutical companies capable of translating market dominance into revenue growth.
Automation & Software Investment Theme Overview
Recent labor data reveals a split market, with low private-sector jobless claims contrasting with high unemployment driven by federal layoffs. This dynamic creates an investment opportunity in companies providing automation, software, and efficiency-boosting services as businesses prioritize productivity over expanding their payrolls.
Oyo's IPO Plans: Hospitality Sector Recovery Explained
Global hospitality firm Oyo's parent company has revived its IPO plans, signaling renewed confidence in the travel market. This high-profile listing could ignite investor interest across the entire hospitality and travel technology sector, creating opportunities for related service providers.